Evaluation of the Value of Perianal Infiltration During Thermodestruction of Haemorrhoidal Disease by Radiofrequency (RAFAELOCAL)
Primary Purpose
Hemorrhoids
Status
Recruiting
Phase
Phase 4
Locations
France
Study Type
Interventional
Intervention
Ropivacaine
Failure to perform peri-anal ropivacaine infiltration
Sponsored by
About this trial
This is an interventional supportive care trial for Hemorrhoids
Eligibility Criteria
Inclusion Criteria:
- Major patient
- Patient scheduled to undergo hemorrhoidal thermodestruction surgery (RAFAELO® procedure)
- Patient able to understand the protocol and having given written informed consent to participate in the study
- Patient affiliated to the social security system or entitled to it
Exclusion Criteria:
- Patient < 18 years old
- Patient with previous hemorrhoidectomy surgery (LONGO technique)
- Patient with previous pexy ligation surgery (HAL-RAR technique)
- Patients with known hypersensitivity to local anaesthetics or components
- Patient with a long term (>1 month) analgesic treatment (level II and III)
- Patient participating in another interventional clinical research protocol involving a drug or clinical investigation of a medical device
- Patient who is pregnant, breastfeeding or able to procreate without contraception
- Patient under guardianship, curatorship or deprived of liberty
Sites / Locations
- Centre Hospitalier Départemental VendéeRecruiting
- Centre Hospitalier Universitaire de Nantes
- Clinique Mutualiste de l'Estuaire
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
Peri-anal infiltration of Ropivacaine
Failure to perform peri-anal ropivacaine infiltration
Arm Description
Outcomes
Primary Outcome Measures
Visual Analogue Scale (VAS) of pain
Minimum value = 0 Maximum value = 10
Secondary Outcome Measures
Full Information
NCT ID
NCT05519189
First Posted
August 25, 2022
Last Updated
January 12, 2023
Sponsor
Centre Hospitalier Departemental Vendee
1. Study Identification
Unique Protocol Identification Number
NCT05519189
Brief Title
Evaluation of the Value of Perianal Infiltration During Thermodestruction of Haemorrhoidal Disease by Radiofrequency
Acronym
RAFAELOCAL
Official Title
Evaluation of the Value of Perianal Infiltration During Thermodestruction of Haemorrhoidal Disease by Radiofrequency
Study Type
Interventional
2. Study Status
Record Verification Date
January 2023
Overall Recruitment Status
Recruiting
Study Start Date
January 10, 2023 (Actual)
Primary Completion Date
January 2025 (Anticipated)
Study Completion Date
February 2025 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Centre Hospitalier Departemental Vendee
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Haemorrhoidal disease is a common and benign condition (1). Anatomically, there is an external and internal component. Only internal haemorrhoidal disease is managed by radiofrequency. Different levels of severity of internal haemorrhoidal disease have been defined by the Goligher classification (1). According to the recommendations for clinical practice established by the French National Society of ColoProctology (SNFCP), grade I and II haemorrhoidal disease should be managed instrumentally after failure of medical treatment. Grade III and IV haemorrhoidal disease is an indication for surgical management in the first instance or after failure of instrumental treatments. The standard technique is the Milligan and Morgan procedure (pedicle haemorrhoidectomy) described in 1937 (2). This technique consists of the removal of the 3 internal haemorrhoidal bundles. It remains the most effective but is responsible for postoperative complications, in particular pain, haemorrhage, anal strictures and anal incontinence (3), (4). Less aggressive techniques have been developed (Longo technique, HAL-RAR technique). The Longo technique is a circular stapling haemorrhoidopexy. The haemorrhoidal packets are brought up into the anal canal with the help of a circular aggravating forceps removing a collar of rectal mucosa. This removal of the mucosa also allows the vascularisation of the haemorrhoidal venous network to be interrupted. The HAL- RAR technique is a non-resection technique consisting of arterial ligation of the haemorrhoidal packets in order to interrupt the vascularisation supplying the haemorrhoidal packets. This technique can be performed with or without Doppler guidance. Recently, Renshaw et al. described a technique for coagulation of haemorrhoidal bundles using a radiofrequency probe (5).
This technique has shown satisfactory results and is an interesting option in the management of haemorrhoidal disease (6) with low postoperative pain (7).
In order to limit patients' postoperative pain and reduce their apprehension during defecation episodes, a perianal block has been shown to reduce postoperative pain in patients with a haemorrhoidectomy technique (8,9). In 2019, a prospective randomised trial (10) confirmed the value of this perianal block without a neurostimulator during a haemorrhoidal pack resection procedure. A perianal infiltration of 40 ml of 0.5% Ropivacaine was performed. These 40ml were divided into 4 injections of 10ml each in the left and right antero-lateral position and in the left and right postero-lateral position in relation to the anal margin.
The hemorrhoidal pack resection technique is known to induce postoperative pain. Haemorrhoidal radiofrequency (RAFAELO® procedure) is a new minimally invasive technique that reduces postoperative pain and is usually performed on an outpatient basis (6). Currently, peri-anal infiltration is routinely performed for all haemorrhoidal surgery whether or not there is a haemorrhoidal resection. No studies have evaluated the relevance of maintaining peri-anal infiltration in non-resected haemorrhoidal surgery and in particular during radiofrequency haemorrhoidal packets. In addition, ropivacaine infiltration is not without risks. Local anaesthesia has potential risks for the patient:
Adverse reaction or hypersensitivity to local anaesthetics and components
Infection at the injection site or infiltration
Haematoma at the injection or infiltration site The aim of our study is to demonstrate the non-inferiority of discontinuing perianal infiltration in patients with thermodestructive haemorrhoidal surgery.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hemorrhoids
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
134 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Peri-anal infiltration of Ropivacaine
Arm Type
Active Comparator
Arm Title
Failure to perform peri-anal ropivacaine infiltration
Arm Type
Experimental
Intervention Type
Drug
Intervention Name(s)
Ropivacaine
Intervention Description
Peri-anal infiltration of Ropivacaine
Intervention Type
Other
Intervention Name(s)
Failure to perform peri-anal ropivacaine infiltration
Intervention Description
Failure to perform peri-anal ropivacaine infiltration
Primary Outcome Measure Information:
Title
Visual Analogue Scale (VAS) of pain
Description
Minimum value = 0 Maximum value = 10
Time Frame
H6 post-op (6 hours after the start of the operation)
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Major patient
Patient scheduled to undergo hemorrhoidal thermodestruction surgery (RAFAELO® procedure)
Patient able to understand the protocol and having given written informed consent to participate in the study
Patient affiliated to the social security system or entitled to it
Exclusion Criteria:
Patient < 18 years old
Patient with previous hemorrhoidectomy surgery (LONGO technique)
Patient with previous pexy ligation surgery (HAL-RAR technique)
Patients with known hypersensitivity to local anaesthetics or components
Patient with a long term (>1 month) analgesic treatment (level II and III)
Patient participating in another interventional clinical research protocol involving a drug or clinical investigation of a medical device
Patient who is pregnant, breastfeeding or able to procreate without contraception
Patient under guardianship, curatorship or deprived of liberty
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Chloé MOREAU
Phone
251446327
Ext
+33
Email
chloe.moreau@ght85.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Emeric ABET
Organizational Affiliation
Centre Hospitalier Départemental Vendée
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Farouk DRISSI
Organizational Affiliation
Nantes University Hospital
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Yann REDON
Organizational Affiliation
Clinique Mutualiste de l'Estuaire
Official's Role
Principal Investigator
Facility Information:
Facility Name
Centre Hospitalier Départemental Vendée
City
La Roche sur Yon
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Emeric ABET
Facility Name
Centre Hospitalier Universitaire de Nantes
City
Nantes
Country
France
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Emilie DUCHALAIS
Facility Name
Clinique Mutualiste de l'Estuaire
City
Saint-Nazaire
Country
France
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Yann REDON
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Evaluation of the Value of Perianal Infiltration During Thermodestruction of Haemorrhoidal Disease by Radiofrequency
We'll reach out to this number within 24 hrs